These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 21262823)

  • 1. Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis.
    Takiar V; Nishio S; Seo-Mayer P; King JD; Li H; Zhang L; Karihaloo A; Hallows KR; Somlo S; Caplan MJ
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2462-7. PubMed ID: 21262823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PF-06409577 inhibits renal cyst progression by concurrently inhibiting the mTOR pathway and CFTR channel activity.
    Su L; Yuan H; Zhang H; Wang R; Fu K; Yin L; Ren Y; Liu H; Fang Q; Wang J; Guo D
    FEBS Open Bio; 2022 Oct; 12(10):1761-1770. PubMed ID: 35748097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease.
    Yuajit C; Muanprasat C; Gallagher AR; Fedeles SV; Kittayaruksakul S; Homvisasevongsa S; Somlo S; Chatsudthipong V
    Biochem Pharmacol; 2014 Apr; 88(3):412-21. PubMed ID: 24518257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Effects of Panduratin A on Renal Cyst Development in In Vitro and In Vivo Models of Polycystic Kidney Disease.
    Tonum K; Srimai N; Chabang N; Fongsupa S; Tuchinda P; Torres JA; Weimbs T; Soodvilai S
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney disease.
    McCarty MF; Barroso-Aranda J; Contreras F
    Med Hypotheses; 2009 Dec; 73(6):1008-10. PubMed ID: 19570618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease.
    Cebotaru L; Liu Q; Yanda MK; Boinot C; Outeda P; Huso DL; Watnick T; Guggino WB; Cebotaru V
    Kidney Int; 2016 Jul; 90(1):90-9. PubMed ID: 27165822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism and application of metformin in kidney diseases: An update.
    Song A; Zhang C; Meng X
    Biomed Pharmacother; 2021 Jun; 138():111454. PubMed ID: 33714781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pranlukast inhibits renal epithelial cyst progression via activation of AMP-activated protein kinase.
    Pathomthongtaweechai N; Soodvilai S; Chatsudthipong V; Muanprasat C
    Eur J Pharmacol; 2014 Feb; 724():67-76. PubMed ID: 24360935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease.
    Leonhard WN; Song X; Kanhai AA; Iliuta IA; Bozovic A; Steinberg GR; Peters DJM; Pei Y
    EBioMedicine; 2019 Sep; 47():436-445. PubMed ID: 31473186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
    Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
    J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CaMK4 overexpression in polycystic kidney disease promotes mTOR-mediated cell proliferation.
    Zhang Y; Daniel EA; Metcalf J; Dai Y; Reif GA; Wallace DP
    J Mol Cell Biol; 2022 Sep; 14(7):. PubMed ID: 36002021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.
    Jansson K; Venugopal J; Sánchez G; Magenheimer BS; Reif GA; Wallace DP; Calvet JP; Blanco G
    J Membr Biol; 2015 Dec; 248(6):1145-57. PubMed ID: 26289599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin slows liver cyst formation and fibrosis in experimental model of polycystic liver disease.
    Sato Y; Qiu J; Hirose T; Miura T; Sato Y; Kohzuki M; Ito O
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G464-G473. PubMed ID: 33439105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model.
    Talbi K; Cabrita I; Kraus A; Hofmann S; Skoczynski K; Kunzelmann K; Buchholz B; Schreiber R
    FASEB J; 2021 Oct; 35(10):e21897. PubMed ID: 34473378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HL156A, an AMP-Activated Protein Kinase Activator, Inhibits Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.
    Seo S; Kim H; Hwang JT; Kim JE; Kim J; Jeon S; Song YJ; Choi KH; Sim G; Cho M; Yoon JW; Kim H
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)].
    Miranda N; Miranda F; Rinaldi L; Stratigis S; Capasso G
    G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chalcone derivative retards renal cyst enlargement by inhibiting fluid secretion and cell proliferation in an in vitro model of polycystic kidney disease.
    Veeraphan P; Chavasiri W; Muanprasat C; Chatsudthipong V; Yuajit C
    Clin Exp Nephrol; 2021 Sep; 25(9):944-952. PubMed ID: 34057612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic activation of AMP-activated protein kinase leads to early-onset polycystic kidney phenotype.
    Wilson L; Pollard AE; Penfold L; Muckett PJ; Whilding C; Bohlooly-Y M; Wilson P; Carling D
    Clin Sci (Lond); 2021 Oct; 135(20):2393-2408. PubMed ID: 34622923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells.
    Myerburg MM; King JD; Oyster NM; Fitch AC; Magill A; Baty CJ; Watkins SC; Kolls JK; Pilewski JM; Hallows KR
    Am J Respir Cell Mol Biol; 2010 Jun; 42(6):676-84. PubMed ID: 19617399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.